Journal of Clinical Investigation, 131(1):e138332. The American Society for Clinical Investigation Broekaart, D W M, Bertran, A, Jia, S, Korotkov, A, Senkov, O, Bongaarts, A, Mills, J D, Anink, J J, Seco, J, Baayen, J C, Idema, S, Chabrol, E, Becker, A J, Wadman, W J, Tarragó, T, Gorter, J A, Aronica, E, Prades, R, Dityatev, A & van Vliet, E A 2021, ' The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects ', Journal of Clinical Investigation, vol. 131, no. 1, e138332 . https://doi.org/10.1172/JCI138332 J Clin Invest The journal of clinical investigation 131(1), e138332 (2021). doi:10.1172/JCI138332 Journal of clinical investigation, 131(1):e138332. The American Society for Clinical Investigation The journal of clinical investigation, 131(1):e138332. The American Society for Clinical Investigation